Rina Ando

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions

Masahiro Okada, Taro Shimono, Yoshihiro Komeya et al. · Annals of Nuclear Medicine · 2009 · 73 citations

Medicine, Oncology, Radiology +16

Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy

David Adams, Jonas Wixner, Michael Polydefkis et al. · JAMA Neurology · 2025 · 31 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan

Hirotaka Iwaki, Rina Ando, Noriyuki Miyaue et al. · Journal of the Neurological Sciences · 2017 · 28 citations

Medicine, Neurology, Pharmacotherapy +8

A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease

Hirotaka Iwaki, Rina Ando, Satoshi Tada et al. · Journal of the Neurological Sciences · 2020 · 25 citations

Medicine, Pharmacology, Pharmacotherapy +10